TrialGynecologic oncology2025

A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG oncology/GOG study.

Victoria L Bae-Jump et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.